These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 21213068)
1. B cell lymphoma unclassifiable with features intermediate between diffuse large B cell and burkitt lymphoma--presented with multiple lymphomatous polyposis of gastrointestinal tract. Jain D; Agrawal S; Chopra P J Gastrointest Cancer; 2011 Dec; 42(4):282-6. PubMed ID: 21213068 [TBL] [Abstract][Full Text] [Related]
2. Diffuse large B-cell lymphoma presenting as multiple lymphomatous polyposis of the gastrointestinal tract. Andhavarapu S; Tolentino AM; Jha C; Ravi J; Carlson R; Nair GR Clin Lymphoma Myeloma; 2008 Jun; 8(3):179-83. PubMed ID: 18650183 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. Lin P; Dickason TJ; Fayad LE; Lennon PA; Hu P; Garcia M; Routbort MJ; Miranda R; Wang X; Qiao W; Medeiros LJ Cancer; 2012 Mar; 118(6):1566-73. PubMed ID: 21882178 [TBL] [Abstract][Full Text] [Related]
4. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma: report of a case in the oral cavity. Jaradat JM; Potluri A; Bilodeau EA Indian J Dent Res; 2013; 24(3):384-6. PubMed ID: 24025890 [TBL] [Abstract][Full Text] [Related]
5. Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL. Maruyama D; Watanabe T; Maeshima AM; Nomoto J; Taniguchi H; Azuma T; Mori M; Munakata W; Kim SW; Kobayashi Y; Matsuno Y; Tobinai K Int J Hematol; 2010 Dec; 92(5):732-43. PubMed ID: 21120644 [TBL] [Abstract][Full Text] [Related]
6. Non-multiple lymphomatous polyposis form of mantle cell lymphoma in the gastrointestinal tract. Tamura S; Ohkawauchi K; Yokoyama Y; Higashidani Y; Daibata M; Hiroi M; Yamamori S; Onishi S J Gastroenterol; 2004 Oct; 39(10):995-1000. PubMed ID: 15549454 [TBL] [Abstract][Full Text] [Related]
7. Intensive chemotherapy for a patient with primary cutaneous diffuse large B-cell lymphoma with Burkitt-like morphology. Okudaira T; Nagasaki A; Miyagi T; Taira T; Ohshima K; Takasu N Intern Med; 2009; 48(6):475-8. PubMed ID: 19293550 [TBL] [Abstract][Full Text] [Related]
8. Diffuse gastrointestinal involvement of mantle cell lymphoma. Meral M; Demirpençe M; Gönen C; Akarsu M; Kayahan H; Demirkan F; Kargi A; Akpinar H Turk J Gastroenterol; 2008 Jun; 19(2):117-20. PubMed ID: 19110668 [TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal mantle cell lymphoma with isolated mass and multiple lymphomatous polyposis: report of two cases. Yanai S; Nakamura S; Yamaguchi S; Kawasaki K; Ishida K; Sugai T; Umeno J; Esaki M; Matsumoto T Clin J Gastroenterol; 2017 Aug; 10(4):327-330. PubMed ID: 28451951 [TBL] [Abstract][Full Text] [Related]
10. A rare case of multiple lymphomatous polyposis with widespread involvement of the gastrointestinal tract. Remes-Troche JM; De-Anda J; Ochoa V; Barreto-Zuñiga R; Arista-Nasr J; Valdovinos MA Arch Pathol Lab Med; 2003 Aug; 127(8):1028-30. PubMed ID: 12873180 [TBL] [Abstract][Full Text] [Related]
11. Multiple lymphomatous polyposis of the gastrointestinal tract. A clinicopathologically distinctive form of non-Hodgkin's lymphoma of B-cell centrocytic type. O'Briain DS; Kennedy MJ; Daly PA; O'Brien AA; Tanner WA; Rogers P; Lawlor E Am J Surg Pathol; 1989 Aug; 13(8):691-9. PubMed ID: 2665536 [TBL] [Abstract][Full Text] [Related]
12. Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 31 cases. Groupe D'étude des Lymphomes Digestifs. Ruskoné-Fourmestraux A; Delmer A; Lavergne A; Molina T; Brousse N; Audouin J; Rambaud JC Gastroenterology; 1997 Jan; 112(1):7-16. PubMed ID: 8978336 [TBL] [Abstract][Full Text] [Related]
13. Lymphomatous polyposis as primary manifestation of mantle cell lymphoma. Yu SC; Liu KL; Chang LC Eur J Haematol; 2012 Aug; 89(2):185-6. PubMed ID: 22563740 [No Abstract] [Full Text] [Related]
14. Mantle-cell lymphoma (multiple lymphomatous polyposis) of the entire GI tract. Michopoulos S; Petraki K; Matsouka C; Kastritis E; Chrysanthopoulou H; Dimopoulos MA J Clin Oncol; 2008 Mar; 26(9):1555-7. PubMed ID: 18349408 [No Abstract] [Full Text] [Related]
15. A rare case of mantle cell lymphoma as lymphomatous polyposis with widespread involvement of the digestive tract. Chung Kim Yuen C; Tomowiak C; Yacoub M; Barrioz T; Barrioz C; Tougeron D Clin Res Hepatol Gastroenterol; 2011 Jan; 35(1):74-8. PubMed ID: 21074342 [TBL] [Abstract][Full Text] [Related]
16. A case of systemic malignant lymphoma with intestinal involvement of lymphomatous polyposis type. Honda K; Mizuno M; Matsumoto T; Kuroki F; Hoshika K; Iida M; Sakurai T; Shimizu M J Clin Gastroenterol; 1997 Jul; 25(1):362-4. PubMed ID: 9412922 [TBL] [Abstract][Full Text] [Related]
17. Pembrolizumab and lenalidomide induced remission in refractory double-hit lymphoma. Chan TS; Khong PL; Kwong YL Ann Hematol; 2016 Oct; 95(11):1917-8. PubMed ID: 27473194 [No Abstract] [Full Text] [Related]
18. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Thomas DA; Faderl S; O'Brien S; Bueso-Ramos C; Cortes J; Garcia-Manero G; Giles FJ; Verstovsek S; Wierda WG; Pierce SA; Shan J; Brandt M; Hagemeister FB; Keating MJ; Cabanillas F; Kantarjian H Cancer; 2006 Apr; 106(7):1569-80. PubMed ID: 16502413 [TBL] [Abstract][Full Text] [Related]